Business ❯ Pharmaceutical Industry
Stock Market GSK Novo Nordisk Johnson & Johnson Financial Growth Sarepta Therapeutics Eli Lilly Market Reactions Financial Results
The setback removes a challenger to Soleno’s newly approved Vykat XR.
